June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Association between self-reported phosphodiesterase inhibitor use and glaucoma in a representative sample of the US population
Author Affiliations & Notes
  • Stephanie Chen
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Kuldev Singh
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Shan Lin
    Ophthalmology, UCSF, San Francisco, California, United States
  • Footnotes
    Commercial Relationships   Stephanie Chen, None; Kuldev Singh, None; Shan Lin, Allergan (C), Iridex (C)
  • Footnotes
    Support  Stanford University School of Medicine MedScholars Fund
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5609. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Stephanie Chen, Kuldev Singh, Shan Lin; Association between self-reported phosphodiesterase inhibitor use and glaucoma in a representative sample of the US population. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5609.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : While optic neuropathy due to decreased ocular blood flow is a known cause of glaucoma, it is unclear what role systemic phosphodiesterase inhibitors (PDEi) play. We performed a retrospective, cross-sectional study of a nationally representative sample of the US population to investigate the relationship between the most commonly used PDEi, sildenafil and theophylline, and self-reported glaucoma.

Methods : We used the National Health and Nutrition Examination Survey 2005-2008 cycles for this observational study. 7,042 participants, age ≥40 years, responded to a survey item on glaucoma status and were included in the analysis. Multivariate logistic regression models were constructed to evaluate the association between ≥1 year of self-reported PDEi use and prevalent glaucoma. Regressions were adjusted for potential confounding variables, including demographics and general health conditions. Sample weights were used to ensure generalizability of results.

Results : 482 respondents self-reported a diagnosis of glaucoma (Table 1), of which 11 used sildenafil and 18 used theophylline for ≥1 year. Covariates significantly associated with higher odds of glaucoma in univariate analyses included older age, black race, former smoking status, diabetes, hyperlipidemia, myocardial infarction, and stroke (Table 2). In regression analyses adjusted only for age and gender, sildenafil (OR=5.14, CI: 1.17-22.60, p=0.031) and theophylline (OR=3.63, CI: 1.78-7.41, p=0.001) were significantly associated with self-reported glaucoma. These associations held after further adjustment with demographics and general health conditions for both sildenafil (OR=4.59, CI: 1.21-17.40, p=0.026) and theophylline (OR=2.91, CI: 1.44-5.85, p=0.004).

Conclusions : At least 1-year use of sildenafil or theophylline may be associated with self-reported glaucoma, perhaps by diverting blood flow away from the optic nerve.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

Table 1. Demographics and General Health Characteristics of Participants Based On Self-Reported Glaucoma Status

Table 1. Demographics and General Health Characteristics of Participants Based On Self-Reported Glaucoma Status

 

Table 2. Logistic Regression Models for Self-Reported Glaucoma and Risk Factors
† Crude models adjusted only for age and female sex
‡ Adjusted models adjusted for demographics and general health comorbidities
* Univariate regressions performed for each covariate
Odds ratios (OR) are reported with 95% confidence intervals (CI) with two-sided p-values <0.05 deemed statistically significant

Table 2. Logistic Regression Models for Self-Reported Glaucoma and Risk Factors
† Crude models adjusted only for age and female sex
‡ Adjusted models adjusted for demographics and general health comorbidities
* Univariate regressions performed for each covariate
Odds ratios (OR) are reported with 95% confidence intervals (CI) with two-sided p-values <0.05 deemed statistically significant

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×